Rheumatology NewsDon’t let knowledge gaps hold back fracture prevention efforts, experts sayOctober 15, 2019Osteoporosis
Rheumatology NewsMultiple zoledronic acid doses may be needed after stopping denosumabOctober 14, 2019Osteoporosis
Rheumatology NewsRomosozumab benefits prevail, despite renal insufficiencyOctober 7, 2019Osteoporosis
Rheumatology NewsConsider cognitive reframing of osteoporosis to improve adherenceOctober 3, 2019Osteoporosis
Rheumatology NewsOsteoporosis remains a costly burden to older U.S. adultsOctober 3, 2019Osteoporosis
Rheumatology NewsOlder black women have worse outcomes after fragility fractureSeptember 26, 2019Osteoporosis
Rheumatology NewsLumbar spine BMD, bone strength benefits persist after romosozumab-to-alendronate switchSeptember 23, 2019Osteoporosis
Rheumatology NewsVitamin D does not improve bone density, structure in healthy patientsSeptember 23, 2019Osteoporosis
Rheumatology NewsProject ECHO helps osteoporosis specialists connect with PCPsSeptember 21, 2019Osteoporosis
Rheumatology NewsSecondary prevention of osteoporotic fractures lackingSeptember 19, 2019Osteoporosis
Rheumatology NewsHigh-dose teriparatide tops standard dose in boosting BMD in postmenopausal womenSeptember 12, 2019Osteoporosis
Rheumatology NewsHigher BMD linked to family history of diabetes in postmenopausal womenAugust 29, 2019Osteoporosis
Rheumatology NewsZoledronic acid reduces symptomatic periodontal disease in patients with osteoporosisAugust 28, 2019Osteoporosis
Rheumatology NewsZoledronate maintains bone loss after denosumab discontinuationAugust 28, 2019Osteoporosis
Rheumatology NewsHigh-dose vitamin D for bone health may do more harm than goodAugust 27, 2019Osteoporosis
